Q999--Nitric Oxide/Inotherapy
Award Notice Posted
- Solicitation number
- 6912620210176
- Agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Awarded
- to INO Therapeutics LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36C26226P0517 Federal contract award
- NAICS code
- 325120 Industrial Gas Manufacturing
- PSC
- Q999 Medical- Other
- Place of performance
- Department of Veterans Affairs Tucson AZ 85723
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Greater Los Angeles Healthcare System awarded a contract to INO Therapeutics LLC on February 26, 2026, for the provision of nitric oxide-based inhalation therapy products and comprehensive support services. The awarded contract, numbered 36C26226P0517, carries a total value of $71,960.00 and encompasses the complete INOtherapy System, including the INOmax DSIRA Plus delivery system, INOmax nitric oxide for inhalation, maintenance and calibration items, accessories, disposables, pharmaceutical drug supply, training, technical support, equipment maintenance, and pick-up and delivery services. The system is designated for patient care treatment of acute respiratory distress syndrome (ARDS) and acute pulmonary hypertension at the VA facility. INO Therapeutics LLC was selected as the sole provider based on the VA's determination that no other contractor could provide a system with equivalent state-of-the-art capabilities, particularly given the proprietary nature of the delivery technology and integrated support infrastructure required for uninterrupted patient care.
Notice text
The Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System (VAGLAHS) has awarded a contract for nitric oxide-based inhalation therapy which is being used for patient care to treat patients with acute respiratory distress syndrome (ARDS), as well as acute pulmonary hypertension. INO Therapeutics LLC is the manufacturer and sole provider of the current INOtherapy System, INOmax DSIR® Plus delivery system, INOmax® (nitric oxide) for inhalation, and accompanying services and products in the United States. It was determined that no other contractor can provide a system with the same state-of-the-art capabilities. The INOtherapy System offers proprietary technology including the INOmax DSIR® Plus delivery system and unique maintenance and calibration items, accessories, and disposables specific to INOmax®. Additionally, this contract includes comprehensive service and support such as the pharmaceutical drug INOmax® (nitric oxide), necessary delivery devices, training, support, maintenance, and reliable pick-up and delivery services. Such extensive support is crucial for ensuring uninterrupted and effective patient care. Awarded contract 36C26226P0517 to INO THERAPEUTICS LLC for 71960.00 on 2026-02-26.
Files
| File | Type | Posted |
|---|---|---|
| 36C26226P0517_1.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Inhaled Nitric Oxide | Defense Health Agency | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity